A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase-Reference-Cited by-同舟云学术

A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase

Published:2021-01-22 Issue:3 Volume:19 Page:689-700
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Chen Xuejie¹^ORCID,Liu Yizhou²,Furukawa Natsuko³,Jin Da‐Yun¹,Paul Savage G.⁴,Stafford Darrel W.¹,Suhara Yoshitomo³^ORCID,Williams Craig M.²^ORCID,Tie Jian‐Ke¹^ORCID

Affiliation:

1. Department of Biology University of North Carolina at Chapel Hill Chapel Hill NC USA

2. School of Chemistry and Molecular Biosciences University of Queensland Brisbane QLD Australia

3. Department of Bioscience and Engineering College of Systems Engineering and Science Shibaura Institute of Technology Saitama Japan

4. CSIRO Manufacturing Ian Wark Laboratory Melbourne VIC Australia

Funder

Australian Research Council

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15209

Reference71 articles.

1. 30-Year Mortality After Venous Thromboembolism

2. Worldwide Epidemiology of Atrial Fibrillation

3. Anticoagulation Strategies in Patients With Cancer

4. Oral anticoagulants in the management of venous thromboembolism

5. Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VKORC1 polymorphisms and complete resistance to Vitamin K antagonists: About two cases.;BioMedicine;2024-02-28

2. Exploring Novel Vitamin K Derivatives with Anti-SARS-CoV-2 Activity;ACS Omega;2023-11-01

3. The impact of anticoagulation therapy on kidney function in patients with atrial fibrillation and chronic kidney disease;Expert Review of Cardiovascular Therapy;2023-10-18

4. Drug-microbiota interactions: an emerging priority for precision medicine;Signal Transduction and Targeted Therapy;2023-10-09

5. Design of a structure-activity relationship model of vitamin K epoxide reductase (VKORC1) inhibitors combining chemical synthesis of new compounds, enzymatic assays and molecular modelling;Bioorganic & Medicinal Chemistry;2023-10